Creso Pharma : Application for quotation of securities - CPH

Application for quotation of +securities

Announcement Summary

For personal use only

Entity name

CRESO PHARMA LIMITED

Announcement Type

New announcement

Date of this announcement

Wednesday March 02, 2022

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
CPH	ORDINARY FULLY PAID	67,851,467	02/03/2022

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 8

Application for quotation of +securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

CRESO PHARMA LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2	Registered number type	Registration number
ABN	89609406911
1.3	ASX issuer code
CPH

1. The announcement is New announcement
2. Date of this announcement

2/3/2022

Application for quotation of +securities

2 / 8

Application for quotation of +securities

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

For personal use only

Previous Appendix 3B details:
Announcement Date and	Announcement Title	Selected Appendix 3B to submit quotation
Time		request
25-Feb-2022 09:51	New - Proposed issue of securities -
A placement or other type of issue
	CPH

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

Yes

2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B

67,851,467 Options to non-related placement participants, 4,612,320 Ordinary Shares and 4,612,320 Options (subject to shareholder approval) in consideration for Director, Adam Blumenthal's participation into the Placement, and 67,851,467 Options (subject to shareholder approval) as part remuneration to the lead manager to the Placement.

Application for quotation of +securities

3 / 8

Application for quotation of +securities

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

	Placement Details
only	2/3/2022
		ASX +security code and description
		CPH : ORDINARY FULLY PAID
use	Issue date
	Distribution Schedule
		Provide a distribution schedule for the new +securities according to the categories set out in the left hand column -
		including the number of recipients and the total percentage of the new +securities held by the recipients in each
		category.

personalFor				Total percentage of +securities held
Number of +securities held	Number of holders	For example, to enter a value of 50%
				please input as 50.00
	1 - 1,000		%
	1,001	- 5,000		%
	5,001	- 10,000		%
	10,001 - 100,000		%
	100,001 and over		%

Application for quotation of +securities

4 / 8

Application for quotation of +securities

Issue details

Number of +securities to be quoted

67,851,467

For personal use only

Are the +securities being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid? What is the issue price per +security?

AUD - Australian Dollar

AUD 0.06900000

Any other information the entity wishes to provide about the +securities to be quoted

Please note that due to limitations in ASX forms processing, the issued capital shown below is not correct. Please note that as per the Appendix 3H released today, the total 'CPHAM-Performance Rights' on issue is now 1,699,000.

Application for quotation of +securities

5 / 8